NISHITH.TV
Mumbai
Silicon Valley
Bengaluru
Singapore
Mumbai BKC
New Delhi
New York
GIFT City
Locations
Mumbai
Silicon Valley
Bengaluru
Singapore
Mumbai BKC
New Delhi
New York
GIFT City
Research and Articles
Think Tanks
Research at NDA
Research Papers
Research Articles
Policy Papers
Hotline
Imaginarium Ali Gunjan (Global Research Campus)
Japan Desk ジャパンデスク
Hotline
Capital Markets Hotline
Climate Change Related Legal Issues
Companies Act Series
Competition Law Hotline
Corpsec Hotline
Court Corner
Cross Examination
Deal Destination
Debt Funding in India Series
Dispute Resolution Hotline
Education Sector Hotline
FEMA Hotline
Financial Service Update
Food & Beverages Hotline
Funds Hotline
Gaming Law Wrap
GIFT City Express
Green Hotline
HR Law Hotline
iCe Hotline
Insolvency and Bankruptcy Hotline
International Trade Hotlines
Investment Funds: Monthly Digest
IP Hotline
IP Lab
Legal Update
Lit Corner
M&A Disputes Series
M&A Hotline
M&A Interactive
Media Hotline
New Publication
Other Hotline
Pharma & Healthcare Update
Press Release
Private Client Wrap
Private Debt Hotline
Private Equity Corner
Real Estate Update
Realty Check
Regulatory Digest
Regulatory Hotline
Renewable Corner
SEZ Hotline
Social Sector Hotline
Tax Hotline
Technology & Tax Series
Technology Law Analysis
Telecom Hotline
The Startups Series
White Collar and Investigations Practice
Yes, Governance Matters.
Japan Desk ジャパンデスク
Pharma & Healthcare Update
1
2
3
4
TITLE
DATE
Draft Compensation Formula for Clinical Trial Related Injury Proposed
06-12-2014
Additional Compliances for Clinical Trials Prescribed
12-03-2013
Pharma Manufacturers Breathe Easy: Competition Regulator Treats Old Ailment Affecting the Industry
05-27-2013
Rules for Compensation in Clinical Trials Related Injury, Death Notified
02-14-2013
Clinical Trials On Trial
01-30-2013
Bar Coding Requirement For Secondary Level Packaging Of Exported Medicines Enforced On January 1, 2013
01-23-2013
Launch New Drug In 6 Months Or Face Cancellation Of The License
01-18-2013
Pharma Update - II
10-23-2012
Pharma Update - I
09-14-2012
Formula for determining the quantum of compensation to clinical trials subjects proposed
08-24-2012
Compensation for injuries in clinical trials getting regulated Ethics Committee decision final
12-23-2011
FDI in Pharma stays at 100% but with certain restrictions
11-16-2011
Product promotions - Pharma companies under restrictions
08-29-2011
Clinical Trial Related Information Exempted from Disclosure
06-16-2011
Pharma Regulatory Update 2010
02-08-2011
Indian drug authorities to now visit and inspect foreign manufacturers' facilities
01-14-2011
Probiotic foods market in India soon to be regulated
12-26-2009
The noose tightens around adulterated and spurious drugs players
08-27-2009
Revised Mashelkar Committee Report on Patent Law Issues accepted by the Government
08-25-2009
Phase I trials for drugs discovered outside India take a backseat yet again
05-15-2009
Clinical Trials - Added Stringent Measures On Their Way!
04-22-2009
Pay To Participants For Research Related Injuries- Suggests ICMR
11-26-2008
Patentee to be heard in proceedings for compulsory licensing for export
07-08-2008
Novartis' Challenge To Section 3(d) Of Patents Act Dismissed
08-10-2007
Government contemplating to allow Phase I trials in India
08-09-2007
Mashelkar Committee submits its report on patentability of NCE's and micro-organisms
01-18-2007
Recent Mumbai High Court Rulings on Drug Regulations
05-11-2006
Guidelines for Medical Devices notified as "Drugs"
03-02-2006
New Bill to regulate scientific research on humans
12-15-2005
Destination India: Fastest growing Asian hub for clinical trials
10-14-2005